Literature DB >> 23184730

Effects of synthetic A3 adenosine receptor agonists on cell proliferation and viability are receptor independent at micromolar concentrations.

Petr Mlejnek1, Petr Dolezel, Ivo Frydrych.   

Abstract

The question as to whether A3 adenosine receptor (A3AR) agonists, N (6)-(3-iodobenzyl)-adenosine-5'-N- methyluronamide (IB-MECA) and 2-chloro-N (6)-(3-iodobenzyl)-adenosine-5'-N-methyluronamide (Cl-IB-MECA), could exert cytotoxic effects at high concentrations with or without the involvement of A3AR has been a controversial issue for a long time. The initial findings suggesting that A3AR plays a crucial role in the induction of cell death upon treatment with micromolar concentrations of IB-MECA or Cl-IB-MECA were revised, however, the direct and unequivocal evidence is still missing. Therefore, the sensitivity of Chinese hamster ovary (CHO) cells transfected with human recombinant A3AR (A3-CHO) and their counter partner wild-type CHO cells, which do not express any of adenosine receptors, to micromolar concentrations of IB-MECA and Cl-IB-MECA was studied. We observed that IB-MECA and Cl-IB-MECA exhibited a strong inhibitory effect on cell proliferation due to the blockage of cell cycle progression at G1/S and G2/M transitions in both A3-CHO and CHO cells. Further analysis revealed that IB-MECA and Cl-IB-MECA attenuated the Erk1/2 signalling irrespectively to A3AR expression. In addition, Cl-IB-MECA induced massive cell death mainly with hallmarks of a necrosis in both cell lines. In contrast, IB-MECA affected cell viability only slightly independently of A3AR expression. IB-MECA induced cell death that exhibited apoptotic hallmarks. In general, the sensitivity of A3-CHO cells to micromolar concentrations of IB-MECA and Cl-IB-MECA was somewhat, but not significantly, higher than that observed in the CHO cells. These results strongly suggest that IB-MECA and Cl-IB-MECA exert cytotoxic effects at micromolar concentrations independently of A3AR expression.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23184730     DOI: 10.1007/s13105-012-0222-7

Source DB:  PubMed          Journal:  J Physiol Biochem        ISSN: 1138-7548            Impact factor:   4.158


  48 in total

Review 1.  Structure and function of adenosine receptors and their genes.

Authors:  B B Fredholm; G Arslan; L Halldner; B Kull; G Schulte; W Wasserman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2000-11       Impact factor: 3.000

2.  Signaling pathway from the human adenosine A(3) receptor expressed in Chinese hamster ovary cells to the extracellular signal-regulated kinase 1/2.

Authors:  Gunnar Schulte; Bertil B Fredholm
Journal:  Mol Pharmacol       Date:  2002-11       Impact factor: 4.436

3.  p53-Independent induction of Fas and apoptosis in leukemic cells by an adenosine derivative, Cl-IB-MECA.

Authors:  Seong Gon Kim; Gnana Ravi; Carsten Hoffmann; Yun Jin Jung; Min Kim; Aishe Chen; Kenneth A Jacobson
Journal:  Biochem Pharmacol       Date:  2002-03-01       Impact factor: 5.858

4.  Evidence for involvement of Wnt signaling pathway in IB-MECA mediated suppression of melanoma cells.

Authors:  Pnina Fishman; Lea Madi; Sara Bar-Yehuda; Faina Barer; Luis Del Valle; Kamel Khalili
Journal:  Oncogene       Date:  2002-06-06       Impact factor: 9.867

5.  Structure-activity relationships of N6-benzyladenosine-5'-uronamides as A3-selective adenosine agonists.

Authors:  C Gallo-Rodriguez; X D Ji; N Melman; B D Siegman; L H Sanders; J Orlina; B Fischer; Q Pu; M E Olah; P J van Galen
Journal:  J Med Chem       Date:  1994-03-04       Impact factor: 7.446

6.  Apoptosis-related gene transcription in human A549 lung cancer cells via A(3) adenosine receptor.

Authors:  Hitomi Kamiya; Takeshi Kanno; Yumiko Fujita; Akinobu Gotoh; Takashi Nakano; Tomoyuki Nishizaki
Journal:  Cell Physiol Biochem       Date:  2012-05-11

Review 7.  Differential effect of adenosine on tumor and normal cell growth: focus on the A3 adenosine receptor.

Authors:  G Ohana; S Bar-Yehuda; F Barer; P Fishman
Journal:  J Cell Physiol       Date:  2001-01       Impact factor: 6.384

8.  A novel adenosine analog, thio-Cl-IB-MECA, induces G0/G1 cell cycle arrest and apoptosis in human promyelocytic leukemia HL-60 cells.

Authors:  Eun-Jin Lee; Hye-Young Min; Hwa-Jin Chung; Eun-Jung Park; Dae-Hong Shin; Lak Shin Jeong; Sang Kook Lee
Journal:  Biochem Pharmacol       Date:  2005-09-15       Impact factor: 5.858

Review 9.  A glance at adenosine receptors: novel target for antitumor therapy.

Authors:  Stefania Merighi; Prisco Mirandola; Katia Varani; Stefania Gessi; Edward Leung; Pier Giovanni Baraldi; Mojgan Aghazadeh Tabrizi; Pier Andrea Borea
Journal:  Pharmacol Ther       Date:  2003-10       Impact factor: 12.310

Review 10.  Adenosine, an endogenous distress signal, modulates tissue damage and repair.

Authors:  B B Fredholm
Journal:  Cell Death Differ       Date:  2007-03-30       Impact factor: 15.828

View more
  5 in total

1.  Design, Synthesis and Biological Evaluation of 1,3,5-Triazine Derivatives Targeting hA1 and hA3 Adenosine Receptor.

Authors:  Sujin Park; Yujin Ahn; Yongchan Kim; Eun Joo Roh; Yoonji Lee; Chaebin Han; Hee Min Yoo; Jinha Yu
Journal:  Molecules       Date:  2022-06-22       Impact factor: 4.927

Review 2.  Structure-based approaches to ligands for G-protein-coupled adenosine and P2Y receptors, from small molecules to nanoconjugates.

Authors:  Kenneth A Jacobson
Journal:  J Med Chem       Date:  2013-05-09       Impact factor: 7.446

3.  2‑Cl‑IB‑MECA regulates the proliferative and drug resistance pathways, and facilitates chemosensitivity in pancreatic and liver cancer cell lines.

Authors:  Jana Kotulova; Katerina Lonova; Agata Kubickova; Jana Vrbkova; Pavla Kourilova; Marian Hajduch; Petr Dzubak
Journal:  Int J Mol Med       Date:  2022-01-18       Impact factor: 4.101

Review 4.  Cancer biology and molecular genetics of A3 adenosine receptor.

Authors:  Chiara Mazziotta; John Charles Rotondo; Carmen Lanzillotti; Giulia Campione; Fernanda Martini; Mauro Tognon
Journal:  Oncogene       Date:  2021-11-08       Impact factor: 9.867

5.  A3 Adenosine Receptor Antagonists with Nucleoside Structures and Their Anticancer Activity.

Authors:  Andrea Spinaci; Michela Buccioni; Diego Dal Ben; Federica Maggi; Gabriella Marucci; Beatrice Francucci; Giorgio Santoni; Catia Lambertucci; Rosaria Volpini
Journal:  Pharmaceuticals (Basel)       Date:  2022-01-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.